Related references
Note: Only part of the references are listed.Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax- induced apoptosis
I. Szabo et al.
CELL DEATH AND DIFFERENTIATION (2011)
Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo
Soo Hwa Jang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Identification of a voltage-gated potassium channel in gerbil hippocampal mitochondria
Piotr Bednarczyk et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtK(Ca)3.1
Nicola Sassi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes
Erich Gulbins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo
P. D. Koeberle et al.
CELL DEATH AND DIFFERENTIATION (2010)
Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints
Luigi Leanza et al.
EXPERIMENTAL CELL RESEARCH (2010)
Interaction of mitochondrial potassium channels with the permeability transition pore
Yu Cheng et al.
FEBS LETTERS (2010)
Contribution of voltage-gated potassium channels to the regulation of apoptosis
Ildiko Szabo et al.
FEBS LETTERS (2010)
Kv1.3 voltage-gated K+ channel subunit as a potential diagnostic marker and therapeutic target for breast cancer
Soo Hwa Jang et al.
BMB REPORTS (2009)
Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
J. Bielanska et al.
CURRENT CANCER DRUG TARGETS (2009)
Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic Therapy
A. Arcangeli et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The functional network of ion channels in T lymphocytes
Michael D. Cahalan et al.
IMMUNOLOGICAL REVIEWS (2009)
Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes
Yunzhao R. Ren et al.
PLOS ONE (2008)
Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes
Ildiko Szabo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pharmacokinetics, toxicity, and functional studies of the selective kv1.3 channel blocker 5-(4-Phenoxybutoxy)Psoralen in rhesus Macaques
L. E. Pereira et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells
Miriam Puttini et al.
CANCER RESEARCH (2006)
Reduced Kv1.3 potassium channel expression in human prostate cancer
Mansoor Abdul et al.
JOURNAL OF MEMBRANE BIOLOGY (2006)
Deficiency in apoptotic effectors bax and bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum
E. Buytaert et al.
AUTOPHAGY (2006)
Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells
M Lan et al.
CANCER BIOLOGY & THERAPY (2005)
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels
GA Gutman et al.
PHARMACOLOGICAL REVIEWS (2005)
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases
A Schmitz et al.
MOLECULAR PHARMACOLOGY (2005)
Rax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis
MG Annis et al.
EMBO JOURNAL (2005)
A novel potassium channel in lymphocyte mitochondria
I Szabò et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol
MH Pourgholami et al.
CANCER LETTERS (2004)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells
J Han et al.
LEUKEMIA (2004)
Kv1.3-blocking 5-phenylalkoxypsoralens:: A new class of immunomodulators
J Vennekamp et al.
MOLECULAR PHARMACOLOGY (2004)
Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas
K Preussat et al.
NEUROSCIENCE LETTERS (2003)
Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents
Y Zhou et al.
BLOOD (2003)
BAX and BAK regulation of endoplasmic reticulum Ca2+:: A control point for apoptosis
L Scorrano et al.
SCIENCE (2003)
Molecular proximity of Kv1.3 voltage-gated potassium channels and β1-integrins on the plasma membrane of melanoma cells:: Effects of cell adherence and channel blockers
VV Artym et al.
JOURNAL OF GENERAL PHYSIOLOGY (2002)
Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells
GAM Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
A role for mitochondrial Bak in apoptotic response to anticancer drugs
GQ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Calcium-activated potassium channels sustain calcium signaling in T lymphocytes - Selective blockers and manipulated channel expression levels
CM Fanger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution
Y Ionov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
